unitedhealthcare glp 1 2025 GLP-1 Shortage = Over Bending the Cost Curve: Understanding

Compounded Semaglutide is the established first-line option with an extensive clinical evidence base

Ozempic may cause secondary weight reduction in adults with type 2 diabetes, but it is not licensed for obesity treatment under PGD

Plus the additional vitamins were a real mood and energy booster

Consequently, exogenous drugs that act on GLP-1Rs increase insulin sensitivity, possibly because GLP-1R stimulation compensates for some of the impaired insulin signaling

Medication costs fluctuate: The price might change based on the dose you get from the medication

You get a physician relationship with someone who knows GLP-1 medications well, regular monitoring, and enough medical depth to handle most complications, but without the institutional overhead